Sign inGet started

Wapnick Pamela

Insider CIK 1995657 · MGX Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MGX Metagenomi Therapeutics, I S Sale2026-09-082026-09-101,911$1.16 $2.2K206,580SEC↗
MGX Metagenomi Therapeutics, I S Sale2026-09-082026-09-101,911$1.16 $2.2K206,580SEC↗
MGX Metagenomi Therapeutics, I S Sale2026-06-052026-06-102,884$1.30 $3.7K208,491SEC↗
MGX Metagenomi Therapeutics, I A Award deriv2026-04-012026-04-03144,000— $0144,000SEC↗
MGX Metagenomi Therapeutics, I A Award2026-04-012026-04-0324,000— $0211,375SEC↗
MGX Metagenomi Therapeutics, I S Sale2026-03-052026-03-091,581$1.60 $2.5K187,375SEC↗
MGX Metagenomi, Inc. S Sale2025-12-052025-12-081,576$1.77 $2.8K188,956SEC↗
MGX Metagenomi, Inc. A Award2025-12-012025-12-01120,000$1.60 $192.0K190,532SEC↗
MGX Metagenomi, Inc. S Sale2025-09-052025-12-011,576$1.81 $2.9K70,532SEC↗
MGX Metagenomi, Inc. S Sale2025-06-062025-06-091,576$1.75 $2.8K72,108SEC↗
MGX Metagenomi, Inc. A Award deriv2025-04-012025-04-0384,000— $084,000SEC↗
MGX Metagenomi, Inc. A Award2025-04-012025-04-0314,000— $073,684SEC↗
MGX Metagenomi, Inc. S Sale2025-03-052025-03-071,808$1.87 $3.4K59,684SEC↗
MGX Metagenomi, Inc. S Sale2024-12-052024-12-061,559$1.86 $2.9K61,492SEC↗
MGX Metagenomi, Inc. S Sale2024-09-052024-09-066,265$2.88 $18.0K63,051SEC↗
MGX Metagenomi, Inc. A Award deriv2024-04-012024-04-03291,450— $0291,450SEC↗
MGX Metagenomi, Inc. A Award2024-04-012024-04-0369,316— $069,316SEC↗